Hyperpigmentation due to pyrimethamine use

J Dermatol. 2002 Jul;29(7):443-5. doi: 10.1111/j.1346-8138.2002.tb00303.x.

Abstract

Pyrimethamine is used for the treatment of toxoplasmosis and the prophylaxis of malaria. Among the well-documented side effects are megaloblastic anemia, leukopenia, thrombopenia, rash, vomiting, and diarrhea. Hyperpigmentation is a very rare side effect. In some patients, associated HIV infection makes it difficult to distinguish the reasons for the etiology. We herein describe an HIV-negative patient who developed hyperpigmentation after pyrimethamine use.

Publication types

  • Case Reports

MeSH terms

  • Adult
  • Antiprotozoal Agents / adverse effects*
  • Antiprotozoal Agents / therapeutic use
  • Facial Dermatoses / chemically induced
  • Female
  • Follow-Up Studies
  • HIV Seronegativity
  • Humans
  • Hyperpigmentation / chemically induced*
  • Pyrimethamine / adverse effects*
  • Pyrimethamine / therapeutic use
  • Risk Assessment
  • Toxoplasmosis / diagnosis
  • Toxoplasmosis / drug therapy

Substances

  • Antiprotozoal Agents
  • Pyrimethamine